Data from A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Authors:
- Maryam FouladiMFMaryam Fouladi
- John P. PerentesisJPJohn P. Perentesis
- Lars M. WagnerLWLars M. Wagner
- Alexander A. VinksAVAlexander A. Vinks
- Joel M. ReidJRJoel M. Reid
- Charlotte AhernCACharlotte Ahern
- George ThomasGTGeorge Thomas
- Carol A. MercerCMCarol A. Mercer
- Darcy A. KruegerDKDarcy A. Krueger
- Peter J. HoughtonPHPeter J. Houghton
- L. Austin DoyleLDL. Austin Doyle
- Helen ChenHCHelen Chen
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)